Aurobindo Pharma has informed that the officials of the Company will be participating in the following investor meeting ‘Systematix Group: Virtual Conference’ on March 13, 2023 at 11.00 am virtually. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is submitted pursuant to Regulation 30(6) of the Listing Regulations.
The above information is a part of company’s filings submitted to BSE.